How long does it take different countries/regions to approve new medications? The US is the fastest and Europe is the slowest among selected major pharmaceutical markets according to a report by EFPIA.
![](https://www.healthcare-economist.com/wp-content/uploads/2023/11/time-to-approval.png)
Moreover, while a majority (7 out of 10) of therapies in the US rely on expedited approval, in Europe less than 1 in 10 are approved via these pathways.
![](https://www.healthcare-economist.com/wp-content/uploads/2023/11/expedited-review.png)
You can read EFPIA’s full report and response to the EU pharmaceutical packet here.